Copyright: ©Author(s) 2026.
World J Clin Oncol. Jun 24, 2026; 17(6): 120188
Published online Jun 24, 2026. doi: 10.5306/wjco.120188
Published online Jun 24, 2026. doi: 10.5306/wjco.120188
Figure 1 Effects of Compound Muji Granules combined with cisplatin on the phenotype of alpha-fetoprotein-producing gastric cancer FU97 cells.
A: Cell proliferation; B: Alpha-fetoprotein secretion; C: Cell migration (representative images and quantification); D: Cell invasion (representative images and quantification); E: Cell cycle distribution; F: Cell apoptosis. aP < 0.05. bP < 0.01. cP < 0.001. OD: Optical density; AFP: Alpha-fetoprotein; CMG: Compound Muji Granules; DPP: Cisplatin; RMSD: Root mean square deviation; CV: Coefficient of variation; PE-A: Phycoerythrin-are.
- Citation: Li H, Wang L, Zuo S, He WT, Zhang T. Compound Muji Granules enhances cisplatin efficacy against alpha-fetoprotein-producing gastric cancer by suppressing epidermal growth factor receptor signaling. World J Clin Oncol 2026; 17(6): 120188
- URL: https://www.wjgnet.com/2218-4333/full/v17/i6/120188.htm
- DOI: https://dx.doi.org/10.5306/wjco.120188